Amphetamine

08 December 2009

Products Affected - Description

Amphetamine mixed salts extended release capsules, Teva
5 mg capsules, 100 count (NDC 00555-0790-02)
10 mg capsules, 100 count (NDC 00555-0787-02)
15 mg capsules, 100 count (NDC 00555-0791-02)
20 mg capsules, 100 count (NDC 00555-0788-02)
25 mg capsules, 100 count (NDC 00555-0792-02)
30 mg capsules, 100 count (NDC 00555-0789-02)

Reason for the Shortage

Teva has their product on back order due to problems obtaining raw materials.

Estimated Resupply Dates

• Teva has all of their amphetamine mixed salt extended-release capsules on back order with no release date.
• Shire has available their Adderall XR capsules in 5 mg (NDC 54092-0381-01), 10mg (NDC 54092-0383-01), 15 mg (NDC 54092-0385-01), 20 mg (NDC 54092-0387-01), 25 mg (NDC 54092-0389-01) and 30 mg (NDC 54092-0391-01) 100 count bottles.
• Global Pharmaceuticals has available their amphetamine mixed salt extended-release capsules in 5 mg (NDC 00115-1328-01), 10 mg (NDC 00115-1329-01), 15 mg (NDC 00115-1330-01), 20 mg (NDC 00115-1331-01), 25 mg (NDC 00115-1332-01), and 30 mg (NDC 00115-1333-01) 100 count bottles.
  

Related Shortages

• Caffeine/Caffeine and Sodium Benzoate Injection— Resolved

Updated

December 8, 2009; October 30, 2009, University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins